Adrestia Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Adrestia Therapeutics's estimated annual revenue is currently $7M per year.
- Adrestia Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Adrestia Therapeutics has 45 Employees.
- Adrestia Therapeutics grew their employee count by 41% last year.
Adrestia Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Executive Director Head Technology | Reveal Email/Phone |
2 | Research Scientist & Laboratory Manager | Reveal Email/Phone |
3 | Principal Scientist | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
5 | Research Scientist | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
Adrestia Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Adrestia Therapeutics?
Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells.
keywords:N/AN/A
Total Funding
45
Number of Employees
$7M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adrestia Therapeutics News
2022-04-17 - How Adrestia Therapeutics is pioneering synthetic rescue
Spinning out of the academic research of Prof Steve Jackson at the University of Cambridge in 2018, Adrestia Therapeutics is focused on...
2022-03-22 - Adrestia Therapeutics appoints first full-time CEO as it builds synthetic
rescue therapy platform
Adrestia Therapeutics has appointed its first full time CEO as it builds its synthetic rescue therapy platform.
2022-03-22 - Adrestia Appoints Robert Johnson as Chief Executive Officer
CAMBRIDGE, England--(BUSINESS WIRE)-- Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $27M | 45 | -62% | $281.5M |
#2 | $7.6M | 45 | -6% | $128.2M |
#3 | $3.5M | 45 | 18% | N/A |
#4 | $12.7M | 45 | -18% | N/A |
#5 | $3.7M | 45 | 18% | N/A |